Chitosan and its derivatives as nanocarriers for siRNA delivery

被引:14
|
作者
Al-Qadi, S. [1 ]
Grenha, A. [2 ]
Remunan-Lopez, C. [1 ]
机构
[1] Univ Santiago de Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Nanobiofar Grp, Santiago De Compostela 15782, Spain
[2] Univ Algarve, IBB Inst Biotechnol & Bioengn, CBME Ctr Mol & Struct Biomed, Faro, Portugal
关键词
Chitosan; Chitosan derivatives; Formulation parameters; Gene silencing; Nanocarriers; siRNA delivery; SMALL INTERFERING RNA; TARGETED GENE DELIVERY; NUCLEIC-ACID DELIVERY; MOLECULAR-WEIGHT; IN-VITRO; DRUG-DELIVERY; ANTISENSE OLIGONUCLEOTIDES; ANTIINFLAMMATORY TREATMENT; NANOPARTICLE FORMULATION; INTRAVENOUS DELIVERY;
D O I
10.1016/S1773-2247(12)50003-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ability to specifically silence genes using siRNA has enormous potential for treating genetic diseases. However, siRNA instability and biodistribution issues still need to be overcome, and adequate delivery vehicles have proven indispensable in conveying siRNA to its target. Chitosan is a promising biopolymer for siRNA delivery, its interest stemming from its solely, biodegradability, mucoadhesivity, permeation enhancing effect and cationic charge, as well as amenability to undergo chemical modifications. Chitosan and its derivatives can be readily arranged into complexes or nanoparticles able to entrap and carry siRNA. Specific strategies have been adopted to improve chitosan-based vectors with regard to transfectability. However, further efforts cure required to verify their value and adapt them to enhance therapeutic output prior to clinical application. This review emphasizes the potential of chitosan and its derivatives to develop nanocarriers for siRNA delivery. The properties of chitosan that are significant for transfectability and the most relevant findings are assessed.
引用
下载
收藏
页码:29 / 42
页数:14
相关论文
共 50 条
  • [21] Nanocarriers for siRNA delivery to overcome cancer multidrug resistance
    MENG QingShuo
    YIN Qi
    LI YaPing
    Science Bulletin, 2013, (33) : 4021 - 4030
  • [22] Nanocarriers for siRNA delivery to overcome cancer multidrug resistance
    Meng QingShuo
    Yin Qi
    Li YaPing
    CHINESE SCIENCE BULLETIN, 2013, 58 (33): : 4021 - 4030
  • [23] Polymeric Nanocarriers for siRNA Delivery: Challenges and Future Prospects
    Cun, Dongmei
    Jensen, Linda Boye
    Nielsen, Hanne Morck
    Moghimi, Moein
    Foged, Camilla
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2008, 4 (03) : 258 - 275
  • [24] Nanocarriers: a tool to overcome biological barriers in siRNA delivery
    Kumari, Avnesh
    Kumar, Vineet
    Yadav, Sudesh Kumar
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (10) : 1327 - 1339
  • [25] Nanocarriers for siRNA based on cationic polymers: chitosan and TAT peptide
    Katas, H.
    Somavarapu, S.
    Alpar, H. O.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S54 - S54
  • [26] Development of flexible nanocarriers for siRNA delivery into tumor tissue
    Jung, Hyunkyung
    Shimatani, Yuri
    Hasan, Mahadi
    Uno, Kohei
    Hama, Susumu
    Kogure, Kentaro
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 516 (1-2) : 258 - 265
  • [27] Efficiency of Chitosan-Coated PLGA Nanocarriers for Cellular Delivery of siRNA and CRISPR/Cas9 Complex
    Srivastav, Ashu
    Gupta, Kritika
    Chakraborty, Debojyoti
    Dandekar, Prajakta
    Jain, Ratnesh
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2022, 17 (01) : 180 - 193
  • [28] Efficiency of Chitosan-Coated PLGA Nanocarriers for Cellular Delivery of siRNA and CRISPR/Cas9 Complex
    Ashu Srivastav
    Kritika Gupta
    Debojyoti Chakraborty
    Prajakta Dandekar
    Ratnesh Jain
    Journal of Pharmaceutical Innovation, 2022, 17 : 180 - 193
  • [29] Chitosan based nanocarriers for indomethacin ocular delivery
    Badawi, Alia A.
    El-Laithy, Hanan M.
    El Qidra, Riad K.
    El Mofty, Hala
    El Dally, Mohamed
    ARCHIVES OF PHARMACAL RESEARCH, 2008, 31 (08) : 1040 - 1049
  • [30] Chitosan based nanocarriers for indomethacin ocular delivery
    Alia A. Badawi
    Hanan M. El-Laithy
    Riad K. El Qidra
    Hala El Mofty
    Mohamed El dally
    Archives of Pharmacal Research, 2008, 31